REQUEST A DEMO
Total
USD $0.00
Search more companies

MegaPro Biomedical Co., Ltd. (巨生生医股份有限公司) (Taiwan, China)

Main Activities: Medical Laboratories
Full name: MegaPro Biomedical Co., Ltd. Profile Updated: June 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

MegaPro Biomedical Co., Ltd. is a technology company focusing on the development of niche nano-drugs. The company uses nanoparticles and nanocells as its core technologies, and the industry chain is positioned at the added value of pre-clinical trials in human clinical and early human pre-clinical trials. The company was founded in 2014 and is headquartered in Hsinchu County, Taiwan.

Headquarters
10F.-1, No. 66, Shengyi 5Th Rd
Hsinchu City; Hsinchu City;

Contact Details: Purchase the MegaPro Biomedical Co., Ltd. (巨生生医股份有限公司) report to view the information.

Website: http://www.megaprobio.com

Basic Information
Total Employees:
Purchase the MegaPro Biomedical Co., Ltd. (巨生生医股份有限公司) report to view the information.
Outstanding Shares:
Purchase the MegaPro Biomedical Co., Ltd. (巨生生医股份有限公司) report to view the information.
Financial Auditors:
Purchase the MegaPro Biomedical Co., Ltd. (巨生生医股份有限公司) report to view the information.
Incorporation Date:
November 07, 2014
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
5.1%
Purchase this report to view the information.
3.95%
Purchase this report to view the information.
2.17%
Purchase this report to view the information.
1.8%
Purchase this report to view the information.
0.63%
Subsidiaries
Trium
30%
Company Performance
Financial values in the chart are available after MegaPro Biomedical Co., Ltd. (巨生生医股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Total operating revenue
-75.8%
Operating profit (EBIT)
25.69%
EBITDA
28.77%
Net Profit (Loss) for the Period
13.33%
Total Assets
-47.01%
Total Equity
-53.21%
Return on Equity (ROE)
-23.17%
Debt/Equity
0.72%
Quick Ratio
-9.68%
Cash Ratio
-8.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?